Trials / Completed
CompletedNCT00362492
Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement
9-10 Days Versus Prolonged Thromboprophylaxis in Patients Without Evidence of Ultrasound Proximal Thromboembolism After Total Knee Joint Replacement: a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 850 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 46 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether stopping Low Molecular Weight Heparin (LMWH) thromboprophylaxis is safe after total knee joint replacement. The investigators select patients without proximal thromboembolism assessed by bilateral venous ultrasound examination 7-10 days after surgery. the investigators hypothesis is that stopping thromboprophylaxis is equally effective than prolonging thromboprophylaxis in order to prevent post-surgery complications in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Bilateral ultrasound examination 7+/- 2 after surgery |
Timeline
- Start date
- 2004-06-01
- Completion
- 2007-06-01
- First posted
- 2006-08-10
- Last updated
- 2010-10-28
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00362492. Inclusion in this directory is not an endorsement.